Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stocks: Bill Gross Buys Shares of a Pimco Fund and Sanofi Buys Shares of Regeneron Pharmaceuticals

By

Plus, purchases at Great American Group and Kratos Defense.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • Global and diversified health-care company Sanofi (NYSE:SNY) bought 190,751 shares of integrated biopharmaceutical company Regeneron Pharmaceuticals (NASDAQ:REGN) for $57,233,716.
  • Andrew Gumaer, Chairman and CEO of asset valuation and appraisal services company Great American Group (OTCBB:GAMR), bought 6,720,000 shares of company stock for $1,680,000.
  • William Hoglund, a director at leading national security solutions provider Kratos Defense (NASDAQ:KTOS), bought 200,000 shares of company stock for $1,447,426.
  • Bill Gross, co-founder of Pimco, bought 34,579 shares of Pimco Dynamic Income Fund (NYSE:PDI) for $1,137,649. 
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$57,233,716
2
DIR,BO
JB*
$38,500,868
3
BO
JB*
$3,423,000
4
DIR
JB*
$3,274,320
5
BO
JB*
$2,115,000
6
CB,CEO
JB*
$1,680,000
7
DIR
B
$1,447,426
8
O
B
$1,137,649
9
CEO,DIR
B
$585,634
10
DIR
B
$515,300

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR,BO
JS*
$744,000,000
2
BO
S
$22,590,210
3
CB,CEO,BO
S
$20,969,582
4
DIR,BO
JS*
$18,859,830
5
BO
JS*,S
$17,934,000
6
DIR,BO
JS*
$13,965,000
7
DIR
S
$10,712,045
8
CEO,DIR
JS*
$5,978,000
9
DIR
AS
$3,915,758
10
VP,SO
JS*
$3,699,500

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
No positions in stocks mentioned.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE